Swetha Joswala, PhD
About Swetha Joswala, PhD
Swetha Joswala, PhD, is a Scientist I at Tessera Therapeutics in Cambridge, Massachusetts, with expertise in advanced genome editing technologies and molecular biology techniques. She has a diverse background in research and teaching, having previously worked at Cleveland State University and St. Jude Children's Research Hospital.
Work at Tessera Therapeutics
Swetha Joswala has been employed as a Scientist I at Tessera Therapeutics since 2021. The company is located in Cambridge, Massachusetts, where she has contributed to various projects over the past three years. Her role involves utilizing advanced genome editing technologies and molecular biology techniques to support the company's research initiatives.
Previous Experience in Research and Academia
Before joining Tessera Therapeutics, Swetha Joswala worked at Cleveland State University as a Research and Teaching Assistant from 2014 to 2020. She also served as a Senior Research Technologist at St. Jude Children's Research Hospital for eight months in 2021. These positions provided her with a strong foundation in research methodologies and teaching in the field of cellular and molecular biology.
Education and Expertise
Swetha Joswala earned her Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology from Cleveland State University, where she studied from 2014 to 2020. She also holds a Master's degree in Microbiology from GITAM University, obtained between 2010 and 2012, and a Bachelor's degree in Biotechnology, Microbiology, and Chemistry from Andhra University, completed from 2007 to 2010. Her educational background supports her expertise in advanced genome editing technologies, including CRISPR/Cas9.
Technical Skills and Research Techniques
Swetha Joswala possesses extensive experience in confocal microscopy, including laser scanning and spinning disc techniques. She is skilled in various molecular biology techniques such as in-vitro transcription, western blotting, and DNA sequencing. Additionally, she is proficient in cloning techniques, including Restriction, Gibson, and Gateway cloning, and has practical experience in C. elegans maintenance and microinjection techniques.